High-Fiber Diet for Satiety
(FEMS Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing a high fiber diet made from peas on overweight/obese adults and those with metabolic syndrome. The diet aims to slow nutrient absorption and produce substances in the gut that increase fullness and improve health. Pea fiber has been studied for its potential to improve weight control and metabolic health in overweight and obese adults.
Will I have to stop taking my current medications?
The trial allows participants to continue taking statin drugs, anti-hypertensives, and anti-depressants as long as they do not affect appetite, body weight, or the microbiome. However, you cannot take medications that affect the gut microbiome or appetite.
What data supports the effectiveness of the high-fiber diet treatment for satiety?
Research shows that psyllium, a key component of the high-fiber diet, can delay stomach emptying and reduce hunger, which may help people feel fuller for longer. Additionally, psyllium has been effective in weight loss and improving cholesterol levels, suggesting it can support overall health and satiety.12345
Is a high-fiber diet using psyllium generally safe for humans?
Psyllium, a type of dietary fiber, is generally safe for humans when used properly, but it should not be consumed in dry granular form as it can cause esophageal obstruction (blockage in the throat). It is important to mix psyllium with liquid before consuming to avoid this risk. In studies, psyllium has been well tolerated with no significant side effects reported.56789
How does the high-fiber diet treatment for satiety differ from other treatments?
The high-fiber diet treatment, using psyllium, is unique because it focuses on increasing satiety by delaying gastric emptying and reducing hunger, which can help control appetite and manage weight. Unlike other treatments that may require high doses or have a strong taste, psyllium is effective at a moderate dose and is relatively easy to incorporate into a diet.2351011
Research Team
Eligibility Criteria
This trial is for overweight/obese men and women aged 20-55 with a large waistline, stable weight, pre-diabetes or high cholesterol who are not on special diets or taking medications affecting appetite or the microbiome. They must be willing to eat a research diet and provide blood and fecal samples.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a high fiber or low fiber dietary intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
Microbiome Analysis
Fecal samples are collected for microbiome analyses using 16rRNA technique
Treatment Details
Interventions
- Dietary fiber (Behavioural Intervention)
Dietary fiber is already approved in Canada for the following indications:
- Constipation
- Bowel irregularity
- High cholesterol
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
Mun Y. Choi
University of Missouri-Columbia
Chief Executive Officer since 2017
PhD in Mechanical and Aerospace Engineering from Princeton University
Richard Barohn
University of Missouri-Columbia
Chief Medical Officer since 2020
MD from the University of Missouri-Columbia School of Medicine